US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 24, 2022 (5 years ago)

PEPTIME Energy

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations

What was recalled

PEPTIME Energy (caffeine 250mg) tablets, packaged in a) 6 count packets and b) 100-count bottles, Marketed by: DMD Pharmaceuticals, A Division of Dickery Consumer Products, Inc., Noblesville, IN 46060.

Recalling firm
Ultra Seal Corporation
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0504-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Caffeine recalls

See all
Class II · Moderate risk Ongoing

Acetaminophen 500mg Caffeine 65mg caplets

Reason Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.

Aero Healthcare NDC 55305-135-01 D-0155-2026
Class I · High risk Ongoing

Healthy Living Acetaminophen

Reason Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Aurobindo Pharma USA Inc NDC 58602-882-21 D-0641-2024
Class II · Moderate risk Terminated

DBI Magnums Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-941-00 D-0554-2022
Class II · Moderate risk Terminated

Coated Back Relief Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-800-00 D-0553-2022
Class II · Moderate risk Terminated

Migrenol Caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-565-00 D-0547-2022